ADVERTISEMENT

Motilal Oswal: Cadila Healthcare’s Controlled Opex Led Better Profitability In Q1

Motilal Oswal has raised its earnings estimates for Cadila Healthcare by 10% for FY21 and 9% for FY22E.

Pills arranged for photograph in Tokyo, Japan (Photographer Kiyoshi Ota/Bloomberg)
Pills arranged for photograph in Tokyo, Japan (Photographer Kiyoshi Ota/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More